Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction
- 1 November 1991
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 6 (8) , 484-486
- https://doi.org/10.1016/0885-3924(91)90005-o
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The Management of Inoperable Gastrointestinal Obstruction in Terminal Cancer PatientsTumori Journal, 1990
- Membrane receptors in the gastrointestinal tractBioscience Reports, 1988
- Characterization of muscarinic receptor subtypes in human tissuesLife Sciences, 1988
- MEDICAL MANAGEMENT OF INTESTINAL OBSTRUCTION IN PATIENTS WITH ADVANCED MALIGNANT DISEASEThe Lancet, 1985
- The use of the syringe driver in terminal care [letter]British Journal of Clinical Pharmacology, 1985
- HUMAN PHARMACOLOGY OF HYOSCINE BUTYLBROMIDEThe Lancet, 1966